RESOLUTION ANALYSIS C.S.S.J.R. 3 By: Huffman Public Health Committee Report (Substituted) BACKGROUND AND PURPOSE A report from the Alzheimer's Association shows that an estimated 6.9 million Americans aged 65 and older are living with Alzheimer's disease, with that number expected to double by 2060. Projections from the World Health Organization indicate that over 55 million people are affected by dementia worldwide, with that number expected to rise to 139 million by 2050. The resolution sponsor has informed the committee that these statistics highlight the growing urgency to invest in research, prevention, and treatment strategies. C.S.S.J.R. 3 seeks to drive innovation and research on dementia, Alzheimer's disease, and Parkinson's disease by requiring the Texas Legislature to establish the Dementia Prevention and Research Institute of Texas, which will be responsible for awarding grants to eligible institutions, supporting research into prevention and treatment strategies, and fostering collaboration between public and private entities. CRIMINAL JUSTICE IMPACT It is the committee's opinion that this resolution does not expressly create a criminal offense, increase the punishment for an existing criminal offense or category of offenses, or change the eligibility of a person for community supervision, parole, or mandatory supervision. RULEMAKING AUTHORITY It is the committee's opinion that this resolution does not expressly grant any additional rulemaking authority to a state officer, department, agency, or institution. ANALYSIS C.S.S.J.R. 3 proposes an amendment to the Texas Constitution to require the legislature to establish the Dementia Prevention and Research Institute of Texas (DPRIT) to do the following: award grants to institutions of learning, advanced medical research facilities, public or private persons, and collaboratives in Texas to provide money for: o research into the causes and means of prevention of, and treatment and rehabilitation for, dementia, Alzheimer's disease, Parkinson's disease, and related disorders; o research, including translational research, to develop therapies, protocols, medical pharmaceuticals, or procedures for the substantial mitigation of the symptoms of dementia, Alzheimer's disease, Parkinson's disease, and related disorders; o facilities, equipment, and other costs related to research on dementia, Alzheimer's disease, Parkinson's disease, and related disorders; and o prevention programs and strategies to mitigate the detrimental health impacts of dementia, Alzheimer's disease, Parkinson's disease, and related disorders; support institutions of learning and advanced medical research facilities and collaboratives in Texas in all stages of: o discovering the causes of dementia, Alzheimer's disease, Parkinson's disease, and related disorders; o developing therapies, protocols, medical pharmaceuticals, or procedures for the substantial mitigation of the symptoms of dementia, Alzheimer's disease, Parkinson's disease, and related disorders from laboratory research to clinical trials; and o developing programs to address access to advanced treatment for dementia, Alzheimer's disease, Parkinson's disease, and related disorders; and establish the appropriate standards and oversight bodies to ensure the proper use of funding authorized under the resolution's provisions, including facilities development. C.S.S.J.R. 3 authorizes the members of the governing body and any other decision-making body of DPRIT to serve six-year terms and establishes the Dementia Prevention and Research Fund as a special fund in the state treasury outside the general revenue fund to be administered by DPRIT. The resolution requires the comptroller of public accounts to credit to general revenue interest due to the fund. C.S.S.J.R. 3 requires the comptroller, on January 1, 2026, to transfer $3 billion from the state's general revenue fund to the Dementia Prevention and Research Fund. This transfer is not an appropriation of state tax revenues for the purposes of restriction on the rate of growth of appropriations under the Texas Constitution. This requirement expires January 1, 2029. C.S.S.J.R. 3 establishes that the Dementia Prevention and Research Fund consists of the following: money transferred to the fund; money the legislature appropriates, credits, or transfers to the fund; and gifts and grants, including grants from the federal government, and other donations received for the fund. C.S.S.J.R. 3 authorizes DPRIT, as established by general law, to use money in the Dementia Prevention and Research Fund only for the purpose of funding the following: grants for research on dementia, Alzheimer's disease, Parkinson's disease, and related disorders, research facilities, and research opportunities in Texas: o for the prevention, treatment, and rehabilitation of dementia, Alzheimer's disease, Parkinson's disease, and related disorders and the mitigation of the incidence of and detrimental health impacts from dementia, Alzheimer's disease, Parkinson's disease, and related disorders; and o to develop therapies, protocols, medical pharmaceuticals, or procedures for the substantial mitigation of the symptoms of dementia, Alzheimer's disease, Parkinson's disease, and related disorders; the purchase, construction, or renovation, subject to the institute's approval, of facilities by or on behalf of a state agency or grant recipient; and the institute's operation. C.S.S.J.R. 3 caps the amount the legislature may appropriate from the fund to DPRIT for a state fiscal year at $300 million, not including any unspent money appropriated to DPRIT carried forward from the preceding state fiscal year. The resolution requires a grant recipient to have available, before DPRIT may award a grant, an unexpended amount of money equal to one-half of the grant amount dedicated to the research specified in the grant proposal. The resolution requires the reasonable expenses of managing the assets of the Dementia Prevention and Research Fund to be paid from the fund. ELECTION DATE The constitutional amendment proposed by this joint resolution will be submitted to the voters at an election to be held November 4, 2025. COMPARISON OF SENATE ENGROSSED AND SUBSTITUTE While C.S.S.J.R. 3 may differ from the engrossed in minor or nonsubstantive ways, the following summarizes the substantial differences between the engrossed and committee substitute versions of the resolution. The substitute makes the resolution's provisions applicable to Alzheimer's disease, Parkinson's disease, and related disorders by replacing the engrossed version's references to "dementia and related disorders" with references to "dementia, Alzheimer's disease, Parkinson's disease, and related disorders."
RESOLUTION ANALYSIS
# RESOLUTION ANALYSIS
C.S.S.J.R. 3
By: Huffman
Public Health
Committee Report (Substituted)
C.S.S.J.R. 3
By: Huffman
Public Health
Committee Report (Substituted)
BACKGROUND AND PURPOSE A report from the Alzheimer's Association shows that an estimated 6.9 million Americans aged 65 and older are living with Alzheimer's disease, with that number expected to double by 2060. Projections from the World Health Organization indicate that over 55 million people are affected by dementia worldwide, with that number expected to rise to 139 million by 2050. The resolution sponsor has informed the committee that these statistics highlight the growing urgency to invest in research, prevention, and treatment strategies. C.S.S.J.R. 3 seeks to drive innovation and research on dementia, Alzheimer's disease, and Parkinson's disease by requiring the Texas Legislature to establish the Dementia Prevention and Research Institute of Texas, which will be responsible for awarding grants to eligible institutions, supporting research into prevention and treatment strategies, and fostering collaboration between public and private entities.
CRIMINAL JUSTICE IMPACT It is the committee's opinion that this resolution does not expressly create a criminal offense, increase the punishment for an existing criminal offense or category of offenses, or change the eligibility of a person for community supervision, parole, or mandatory supervision.
RULEMAKING AUTHORITY It is the committee's opinion that this resolution does not expressly grant any additional rulemaking authority to a state officer, department, agency, or institution.
ANALYSIS C.S.S.J.R. 3 proposes an amendment to the Texas Constitution to require the legislature to establish the Dementia Prevention and Research Institute of Texas (DPRIT) to do the following: award grants to institutions of learning, advanced medical research facilities, public or private persons, and collaboratives in Texas to provide money for: o research into the causes and means of prevention of, and treatment and rehabilitation for, dementia, Alzheimer's disease, Parkinson's disease, and related disorders; o research, including translational research, to develop therapies, protocols, medical pharmaceuticals, or procedures for the substantial mitigation of the symptoms of dementia, Alzheimer's disease, Parkinson's disease, and related disorders; o facilities, equipment, and other costs related to research on dementia, Alzheimer's disease, Parkinson's disease, and related disorders; and o prevention programs and strategies to mitigate the detrimental health impacts of dementia, Alzheimer's disease, Parkinson's disease, and related disorders; support institutions of learning and advanced medical research facilities and collaboratives in Texas in all stages of: o discovering the causes of dementia, Alzheimer's disease, Parkinson's disease, and related disorders; o developing therapies, protocols, medical pharmaceuticals, or procedures for the substantial mitigation of the symptoms of dementia, Alzheimer's disease, Parkinson's disease, and related disorders from laboratory research to clinical trials; and o developing programs to address access to advanced treatment for dementia, Alzheimer's disease, Parkinson's disease, and related disorders; and establish the appropriate standards and oversight bodies to ensure the proper use of funding authorized under the resolution's provisions, including facilities development. C.S.S.J.R. 3 authorizes the members of the governing body and any other decision-making body of DPRIT to serve six-year terms and establishes the Dementia Prevention and Research Fund as a special fund in the state treasury outside the general revenue fund to be administered by DPRIT. The resolution requires the comptroller of public accounts to credit to general revenue interest due to the fund. C.S.S.J.R. 3 requires the comptroller, on January 1, 2026, to transfer $3 billion from the state's general revenue fund to the Dementia Prevention and Research Fund. This transfer is not an appropriation of state tax revenues for the purposes of restriction on the rate of growth of appropriations under the Texas Constitution. This requirement expires January 1, 2029. C.S.S.J.R. 3 establishes that the Dementia Prevention and Research Fund consists of the following: money transferred to the fund; money the legislature appropriates, credits, or transfers to the fund; and gifts and grants, including grants from the federal government, and other donations received for the fund. C.S.S.J.R. 3 authorizes DPRIT, as established by general law, to use money in the Dementia Prevention and Research Fund only for the purpose of funding the following: grants for research on dementia, Alzheimer's disease, Parkinson's disease, and related disorders, research facilities, and research opportunities in Texas: o for the prevention, treatment, and rehabilitation of dementia, Alzheimer's disease, Parkinson's disease, and related disorders and the mitigation of the incidence of and detrimental health impacts from dementia, Alzheimer's disease, Parkinson's disease, and related disorders; and o to develop therapies, protocols, medical pharmaceuticals, or procedures for the substantial mitigation of the symptoms of dementia, Alzheimer's disease, Parkinson's disease, and related disorders; the purchase, construction, or renovation, subject to the institute's approval, of facilities by or on behalf of a state agency or grant recipient; and the institute's operation. C.S.S.J.R. 3 caps the amount the legislature may appropriate from the fund to DPRIT for a state fiscal year at $300 million, not including any unspent money appropriated to DPRIT carried forward from the preceding state fiscal year. The resolution requires a grant recipient to have available, before DPRIT may award a grant, an unexpended amount of money equal to one-half of the grant amount dedicated to the research specified in the grant proposal. The resolution requires the reasonable expenses of managing the assets of the Dementia Prevention and Research Fund to be paid from the fund.
ELECTION DATE The constitutional amendment proposed by this joint resolution will be submitted to the voters at an election to be held November 4, 2025.
COMPARISON OF SENATE ENGROSSED AND SUBSTITUTE While C.S.S.J.R. 3 may differ from the engrossed in minor or nonsubstantive ways, the following summarizes the substantial differences between the engrossed and committee substitute versions of the resolution. The substitute makes the resolution's provisions applicable to Alzheimer's disease, Parkinson's disease, and related disorders by replacing the engrossed version's references to "dementia and related disorders" with references to "dementia, Alzheimer's disease, Parkinson's disease, and related disorders."
BACKGROUND AND PURPOSE
A report from the Alzheimer's Association shows that an estimated 6.9 million Americans aged 65 and older are living with Alzheimer's disease, with that number expected to double by 2060. Projections from the World Health Organization indicate that over 55 million people are affected by dementia worldwide, with that number expected to rise to 139 million by 2050. The resolution sponsor has informed the committee that these statistics highlight the growing urgency to invest in research, prevention, and treatment strategies. C.S.S.J.R. 3 seeks to drive innovation and research on dementia, Alzheimer's disease, and Parkinson's disease by requiring the Texas Legislature to establish the Dementia Prevention and Research Institute of Texas, which will be responsible for awarding grants to eligible institutions, supporting research into prevention and treatment strategies, and fostering collaboration between public and private entities.
CRIMINAL JUSTICE IMPACT
It is the committee's opinion that this resolution does not expressly create a criminal offense, increase the punishment for an existing criminal offense or category of offenses, or change the eligibility of a person for community supervision, parole, or mandatory supervision.
RULEMAKING AUTHORITY
It is the committee's opinion that this resolution does not expressly grant any additional rulemaking authority to a state officer, department, agency, or institution.
ANALYSIS
C.S.S.J.R. 3 proposes an amendment to the Texas Constitution to require the legislature to establish the Dementia Prevention and Research Institute of Texas (DPRIT) to do the following:
award grants to institutions of learning, advanced medical research facilities, public or private persons, and collaboratives in Texas to provide money for:
o research into the causes and means of prevention of, and treatment and rehabilitation for, dementia, Alzheimer's disease, Parkinson's disease, and related disorders;
o research, including translational research, to develop therapies, protocols, medical pharmaceuticals, or procedures for the substantial mitigation of the symptoms of dementia, Alzheimer's disease, Parkinson's disease, and related disorders;
o facilities, equipment, and other costs related to research on dementia, Alzheimer's disease, Parkinson's disease, and related disorders; and
o prevention programs and strategies to mitigate the detrimental health impacts of dementia, Alzheimer's disease, Parkinson's disease, and related disorders;
support institutions of learning and advanced medical research facilities and collaboratives in Texas in all stages of:
o discovering the causes of dementia, Alzheimer's disease, Parkinson's disease, and related disorders;
o developing therapies, protocols, medical pharmaceuticals, or procedures for the substantial mitigation of the symptoms of dementia, Alzheimer's disease, Parkinson's disease, and related disorders from laboratory research to clinical trials; and
o developing programs to address access to advanced treatment for dementia, Alzheimer's disease, Parkinson's disease, and related disorders; and
establish the appropriate standards and oversight bodies to ensure the proper use of funding authorized under the resolution's provisions, including facilities development.
C.S.S.J.R. 3 authorizes the members of the governing body and any other decision-making body of DPRIT to serve six-year terms and establishes the Dementia Prevention and Research Fund as a special fund in the state treasury outside the general revenue fund to be administered by DPRIT. The resolution requires the comptroller of public accounts to credit to general revenue interest due to the fund.
C.S.S.J.R. 3 requires the comptroller, on January 1, 2026, to transfer $3 billion from the state's general revenue fund to the Dementia Prevention and Research Fund. This transfer is not an appropriation of state tax revenues for the purposes of restriction on the rate of growth of appropriations under the Texas Constitution. This requirement expires January 1, 2029.
C.S.S.J.R. 3 establishes that the Dementia Prevention and Research Fund consists of the following:
money transferred to the fund;
money the legislature appropriates, credits, or transfers to the fund; and
gifts and grants, including grants from the federal government, and other donations received for the fund.
C.S.S.J.R. 3 authorizes DPRIT, as established by general law, to use money in the Dementia Prevention and Research Fund only for the purpose of funding the following:
grants for research on dementia, Alzheimer's disease, Parkinson's disease, and related disorders, research facilities, and research opportunities in Texas:
o for the prevention, treatment, and rehabilitation of dementia, Alzheimer's disease, Parkinson's disease, and related disorders and the mitigation of the incidence of and detrimental health impacts from dementia, Alzheimer's disease, Parkinson's disease, and related disorders; and
o to develop therapies, protocols, medical pharmaceuticals, or procedures for the substantial mitigation of the symptoms of dementia, Alzheimer's disease, Parkinson's disease, and related disorders;
the purchase, construction, or renovation, subject to the institute's approval, of facilities by or on behalf of a state agency or grant recipient; and
the institute's operation.
C.S.S.J.R. 3 caps the amount the legislature may appropriate from the fund to DPRIT for a state fiscal year at $300 million, not including any unspent money appropriated to DPRIT carried forward from the preceding state fiscal year. The resolution requires a grant recipient to have available, before DPRIT may award a grant, an unexpended amount of money equal to one-half of the grant amount dedicated to the research specified in the grant proposal. The resolution requires the reasonable expenses of managing the assets of the Dementia Prevention and Research Fund to be paid from the fund.
ELECTION DATE
The constitutional amendment proposed by this joint resolution will be submitted to the voters at an election to be held November 4, 2025.
COMPARISON OF SENATE ENGROSSED AND SUBSTITUTE
While C.S.S.J.R. 3 may differ from the engrossed in minor or nonsubstantive ways, the following summarizes the substantial differences between the engrossed and committee substitute versions of the resolution.
The substitute makes the resolution's provisions applicable to Alzheimer's disease, Parkinson's disease, and related disorders by replacing the engrossed version's references to "dementia and related disorders" with references to "dementia, Alzheimer's disease, Parkinson's disease, and related disorders."